Items where authors include "Porta, N."

Article

Keaveney, S. orcid.org/0000-0001-7715-0750, Dragan, A., Rata, M. et al. (25 more authors) (2023) Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study. Insights into Imaging, 14 (1). 170.

Choudhury, A., Porta, N., Hall, E. et al. (9 more authors) (2021) Hypofractionated radiotherapy in locally advanced bladder cancer : an individual patient data meta-analysis of the BC2001 and BCON trials. Lancet Oncology, 22 (2). pp. 246-255. ISSN 1470-2045

Mostafid, A.H., Porta, N., Cresswell, J. et al. (14 more authors) (2020) CALIBER - A phase II randomised feasibility trial of chemoablation with mitomycin versus surgical management in low risk non-muscle invasive bladder cancer. BJU International, 125 (6). pp. 817-826. ISSN 1464-4096

Huddart, R., Hall, E., Lewis, R. et al. (9 more authors) (2020) Patient reported quality of life outcomes in patients treated for muscle invasive bladder cancer with radiotherapy +/- chemotherapy in the BC2001 phase III randomised controlled trial. European Urology, 77 (2). pp. 260-268. ISSN 0302-2838

Choudhury, A., West, C.M., Porta, N. et al. (7 more authors) (2017) The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004). British Journal of Cancer, 116 (5). pp. 649-657. ISSN 0007-0920

Franco, P., Porta, N., Holliday, J.D. et al. (1 more author) (2017) Molecular similarity considerations in the licensing of orphan drugs. Drug Discovery Today, 22 (2). pp. 377-381. ISSN 1359-6446

Franco, P., Porta, N., Holliday, J.D. et al. (1 more author) (2014) The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislation. Journal of Cheminformatics, 6 (1). pp. 1-10.